Natixis Amryt Pharma PLC Transaction History
Natixis
- $17.6 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding AMYT
# of Institutions
5Shares Held
142KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY130KShares$01.5% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L210.2KShares$00.01% of portfolio
-
Brewin Dolphin LTD London, X01.12KShares$00.0% of portfolio
-
Burleson & Company, LLC22Shares$00.0% of portfolio
-
Global Frontier Investments LLC Charleston, SC0Shares$00.0% of portfolio
About Amryt Pharma plc
- Ticker AMYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 64,177,000
- Description
- Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...